Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV003448302 | SCV004176031 | likely benign | CDKL5 disorder | 2023-02-20 | reviewed by expert panel | curation | The p.Arg822His variant in CDKL5 is present in 3 XX and 1 XY individuals in gnomAD v3.1.2 (0.0076%) (not sufficient to meet BS1 criteria). Computational analysis prediction tools suggest that the p.Arg822His variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). The p.Arg822His variant is observed in at least 2 unaffected individuals (internal database-GeneDX) (BS2). In summary, the p.Arg822His variant in CDKL5 is classified as Likely Benign based on the ACMG/AMP criteria (BS2, BP4). |
Center for Pediatric Genomic Medicine, |
RCV000420425 | SCV000511256 | uncertain significance | not provided | 2016-11-30 | criteria provided, single submitter | clinical testing | Converted during submission to Uncertain significance. |
Genetic Services Laboratory, |
RCV000503048 | SCV000593966 | uncertain significance | not specified | 2016-03-04 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001034449 | SCV001197805 | likely benign | Developmental and epileptic encephalopathy, 2; Angelman syndrome-like | 2023-10-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000420425 | SCV002567479 | likely benign | not provided | 2021-05-07 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Ambry Genetics | RCV002446647 | SCV002732332 | uncertain significance | Inborn genetic diseases | 2019-07-30 | criteria provided, single submitter | clinical testing | The p.R822H variant (also known as c.2465G>A), located in coding exon 16 of the CDKL5 gene, results from a G to A substitution at nucleotide position 2465. The arginine at codon 822 is replaced by histidine, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003897838 | SCV004708649 | likely benign | CDKL5-related condition | 2023-08-02 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |